Black women are diagnosed with cervical insufficiency more than any other demographic in the U.S. We should be having more conversations about this.

A Planned Parenthood chapter sparked controversy with a Facebook post urging transgender men to get cervical cancer screenings for Men's Health Month.

Planned Parenthood of Southern New England drew a strong reaction after its Facebook post said "trans men are men and need cervical cancer screenings too." ...

The U.S. Food and Drug Administration has approved the country’s first at-home HPV screening device. The test is designed as an alternative to the Pap smear, a procedure that detects precancerous ...

MINNEAPOLIS — Fewer than half of women treated for high-grade cervical dysplasia subsequently received guidance-concordant surveillance, of whom one-third had an abnormal co-test result ...

But on Friday, the FDA approved the first at-home test for cervical cancer screenings that is a less invasive and potentially more accessible alternative to pap smears.

The first at-home cervical cancer screening test has been approved by the Food and Drug Administration, according to the product's manufacturer. It may offer an alternative to traditional in ...

There's a new self-guided way to screen for cervical cancer at home that was approved by the FDA. But doctors caution that it's not for everyone. Here's what you need to know.

First at-home test kit for cervical cancer approved by the FDA, company says Teal Health said Friday the Food and Drug Administration approved its Teal Wand for home use, offering a new way to ...

For the first time, the FDA has just approved a device that lets people screen for cervical cancer from home. Known as the Teal Wand, from the company Teal Health, the prescription device lets ...

The U.S. Food and Drug Administration on Friday approved Teal Health to provide the nation's first at-home test kit to screen for cervical cancer.

Teal Health, the maker of an at-home cervical cancer screening test, says it will give patients an alternative to in-clinic pap smears.